ProfileGDS4132 / 205031_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 84% 81% 87% 86% 84% 83% 86% 86% 83% 85% 81% 76% 79% 84% 83% 79% 78% 85% 82% 80% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101303.82184
GSM201543Muscle PCOS pioglitazone 121268.49281
GSM201544Muscle PCOS pioglitazone 161380.7587
GSM201545Muscle PCOS pioglitazone 201368.26886
GSM201829Muscle PCOS pioglitazone 231333.4984
GSM201830Muscle PCOS pioglitazon 251307.04783
GSM201831Muscle PCOS pioglitazone 271348.67386
GSM201832Muscle PCOS pioglitazone 31339.03586
GSM201833Muscle PCOS pioglitazone 41304.64483
GSM201834Muscle PCOS pioglitazone 81336.95285
GSM201835Muscle PCOS after pioglitazone 102285.65781
GSM201836Muscle PCOS after pioglitazone 122244.10176
GSM201837Muscle PCOS after pioglitazone 162249.87579
GSM201838Muscle PCOS after pioglitazone 202346.79684
GSM201839Muscle PCOS after pioglitazone 232320.74883
GSM201840Muscle PCOS after pioglitazone 252282.75379
GSM201841Muscle PCOS after pioglitazone 272253.97678
GSM201842Muscle PCOS after pioglitazone 32319.06685
GSM201843Muscle PCOS after pioglitazone 42298.67982
GSM201844Muscle PCOS after pioglitazone 82284.18180